Meta-Analysis of the Efficacy and Safety of Finerenone in Diabetic Kidney Disease

Zheng, YN; Ma, S; Huang, QM; Fang, Y; Tan, HJ; Chen, Y; Li, CR

Li, CR (通讯作者)，Hubei Univ Sci & Technol, Xianning Cent Hosp, Dept Nephrol, Affiliated Hosp 1, Xianning 935498128, Peoples R China.;Ma, S (通讯作者)，Hubei Univ Sci & Technol, Xianning Cent Hosp, Dept Anorectal, Affiliated Hosp 1, Xianning, Peoples R China.;Li, CR (通讯作者)，Hubei Univ Sci & Technol, Xianning Med Coll, Xianning, Peoples R China.

KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (4): 219

Abstract

Background: The phase III clinical trial of the nonsteroidal mineralocorticoid receptor antagonist finerenone (BAY 94-8862) has been completed, aiming......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索